147 related articles for article (PubMed ID: 1695950)
1. Inpatient narcotic infusions for patients with cancer pain.
Ferris FD; Kerr IG; De Angelis C; Sone M; Hume S
J Palliat Care; 1990; 6(2):51-9. PubMed ID: 1695950
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use.
Moulin DE; Johnson NG; Murray-Parsons N; Geoghegan MF; Goodwin VA; Chester MA
CMAJ; 1992 Mar; 146(6):891-7. PubMed ID: 1371946
[TBL] [Abstract][Full Text] [Related]
3. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain.
Bruera E; Brenneis C; Michaud M; Bacovsky R; Chadwick S; Emeno A; MacDonald N
Cancer; 1988 Jul; 62(2):407-11. PubMed ID: 2454724
[TBL] [Abstract][Full Text] [Related]
4. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.
Moulin DE; Kreeft JH; Murray-Parsons N; Bouquillon AI
Lancet; 1991 Feb; 337(8739):465-8. PubMed ID: 1704089
[TBL] [Abstract][Full Text] [Related]
5. Myoclonic seizure activity with chronic high-dose spinal opioid administration.
Parkinson SK; Bailey SL; Little WL; Mueller JB
Anesthesiology; 1990 Apr; 72(4):743-5. PubMed ID: 1690960
[No Abstract] [Full Text] [Related]
6. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.
Glare P; Walsh D; Groh E; Nelson KA
Am J Hosp Palliat Care; 2002; 19(5):343-50. PubMed ID: 12269781
[TBL] [Abstract][Full Text] [Related]
8. Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report.
Bruera E; Macmillan K; Selmser P; MacDonald NR
Pain; 1990 Oct; 43(1):91-94. PubMed ID: 1703651
[TBL] [Abstract][Full Text] [Related]
9. I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.
Portenoy RK; Moulin DE; Rogers A; Inturrisi CE; Foley KM
Cancer Treat Rep; 1986 May; 70(5):575-81. PubMed ID: 2423236
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous morphine infusions for terminal pain control: a retrospective review.
Stuart GJ; Davey EB; Wight SE
Drug Intell Clin Pharm; 1986 Dec; 20(12):968-72. PubMed ID: 2434292
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
12. Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride.
Katcher J; Walsh D
J Pain Symptom Manage; 1999 Jan; 17(1):70-2. PubMed ID: 9919868
[TBL] [Abstract][Full Text] [Related]
13. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
Leng G; Finnegan MJ
Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
[TBL] [Abstract][Full Text] [Related]
14. Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care.
Fudin J; Smith HS; Toledo-Binette CS; Kenney E; Yu AB; Boutin R
Am J Hosp Palliat Care; 2000; 17(5):347-53. PubMed ID: 11886060
[TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. Constant infusion of morphine for intractable cancer pain using an implanted pump.
Hassenbusch SJ; Pillay PK; Magdinec M; Currie K; Bay JW; Covington EC; Tomaszewski MZ
J Neurosurg; 1990 Sep; 73(3):405-9. PubMed ID: 2384779
[TBL] [Abstract][Full Text] [Related]
17. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
Tsui BC; Davies D; Desai S; Malherbe S
J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
[TBL] [Abstract][Full Text] [Related]
18. Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review.
Bentley JN; Viswanathan A; Rosenberg WS; Patil PG
Pain Med; 2014 Sep; 15(9):1488-95. PubMed ID: 24931480
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
[TBL] [Abstract][Full Text] [Related]
20. Opioid withdrawal syndrome on switching from hydromorphone to alfentanil.
McMunnigall F; Welsh J
Palliat Med; 2008 Mar; 22(2):191-2. PubMed ID: 18372384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
